Kristy Crooks
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pathology, Molecular | 2 | 2023 | 25 | 1.020 |
Why?
| Counselors | 1 | 2023 | 12 | 0.850 |
Why?
| Glaucoma, Open-Angle | 4 | 2024 | 103 | 0.700 |
Why?
| Genetic Testing | 7 | 2024 | 425 | 0.550 |
Why?
| Biological Specimen Banks | 4 | 2024 | 101 | 0.520 |
Why?
| Precision Medicine | 5 | 2024 | 386 | 0.480 |
Why?
| Pharmacogenetics | 3 | 2024 | 170 | 0.390 |
Why?
| Genealogy and Heraldry | 1 | 2011 | 5 | 0.380 |
Why?
| Pharmacogenomic Testing | 2 | 2022 | 59 | 0.350 |
Why?
| Genetic Linkage | 1 | 2011 | 299 | 0.350 |
Why?
| Receptor, trkB | 1 | 2010 | 31 | 0.340 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2010 | 55 | 0.330 |
Why?
| Genomics | 6 | 2024 | 716 | 0.330 |
Why?
| Genome-Wide Association Study | 3 | 2025 | 1334 | 0.330 |
Why?
| Space Perception | 1 | 2010 | 73 | 0.320 |
Why?
| Behavior, Animal | 2 | 2010 | 486 | 0.320 |
Why?
| Conditioning, Classical | 1 | 2010 | 97 | 0.320 |
Why?
| High-Throughput Nucleotide Sequencing | 4 | 2023 | 485 | 0.320 |
Why?
| Cytochrome P-450 CYP2C19 | 3 | 2024 | 23 | 0.320 |
Why?
| Decision Support Systems, Clinical | 2 | 2024 | 201 | 0.320 |
Why?
| Cocaine | 1 | 2010 | 150 | 0.290 |
Why?
| Exome | 4 | 2015 | 219 | 0.270 |
Why?
| Polymorphism, Single Nucleotide | 6 | 2025 | 2071 | 0.250 |
Why?
| Cytochrome P-450 CYP2D6 | 2 | 2022 | 29 | 0.240 |
Why?
| Amyloid Neuropathies, Familial | 1 | 2024 | 13 | 0.240 |
Why?
| Prealbumin | 1 | 2024 | 27 | 0.240 |
Why?
| Thyroid Nodule | 1 | 2024 | 51 | 0.210 |
Why?
| Long QT Syndrome | 1 | 2024 | 67 | 0.210 |
Why?
| Multifactorial Inheritance | 1 | 2024 | 148 | 0.210 |
Why?
| Germ Cells | 1 | 2023 | 62 | 0.210 |
Why?
| Models, Genetic | 1 | 2025 | 588 | 0.190 |
Why?
| Genetic Variation | 4 | 2024 | 935 | 0.190 |
Why?
| Genetic Predisposition to Disease | 2 | 2024 | 2273 | 0.190 |
Why?
| Pathologists | 1 | 2021 | 15 | 0.190 |
Why?
| Specimen Handling | 2 | 2021 | 164 | 0.180 |
Why?
| Electrocardiography | 1 | 2024 | 603 | 0.180 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2024 | 453 | 0.170 |
Why?
| Thyroid Neoplasms | 1 | 2024 | 308 | 0.170 |
Why?
| Software | 1 | 2025 | 612 | 0.170 |
Why?
| Diagnosis | 1 | 2018 | 10 | 0.160 |
Why?
| Fellowships and Scholarships | 1 | 2021 | 270 | 0.150 |
Why?
| Incidental Findings | 2 | 2015 | 80 | 0.140 |
Why?
| DNA Copy Number Variations | 1 | 2018 | 172 | 0.140 |
Why?
| Humans | 27 | 2025 | 129078 | 0.140 |
Why?
| Data Collection | 1 | 2020 | 652 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2020 | 473 | 0.140 |
Why?
| Education, Medical, Graduate | 1 | 2021 | 435 | 0.140 |
Why?
| Genome, Human | 2 | 2015 | 393 | 0.130 |
Why?
| Retinal Dystrophies | 1 | 2015 | 5 | 0.120 |
Why?
| Genetic Diseases, Inborn | 1 | 2015 | 38 | 0.120 |
Why?
| Muscle Hypotonia | 1 | 2015 | 32 | 0.120 |
Why?
| Chromosomes, Human, Pair 8 | 2 | 2012 | 36 | 0.120 |
Why?
| Curriculum | 1 | 2021 | 925 | 0.120 |
Why?
| Medicare | 1 | 2020 | 734 | 0.110 |
Why?
| Adult | 13 | 2024 | 35423 | 0.110 |
Why?
| Carbidopa | 1 | 2014 | 4 | 0.110 |
Why?
| GTP Cyclohydrolase | 1 | 2014 | 8 | 0.110 |
Why?
| Mutation | 3 | 2018 | 3679 | 0.110 |
Why?
| Spastic Paraplegia, Hereditary | 1 | 2014 | 9 | 0.110 |
Why?
| Biomedical Research | 1 | 2020 | 654 | 0.110 |
Why?
| Levodopa | 1 | 2014 | 28 | 0.110 |
Why?
| Dopamine Agonists | 1 | 2014 | 39 | 0.110 |
Why?
| Ophthalmology | 1 | 2015 | 79 | 0.110 |
Why?
| Dystonic Disorders | 1 | 2014 | 23 | 0.110 |
Why?
| Seizures | 2 | 2015 | 395 | 0.110 |
Why?
| Abnormalities, Multiple | 1 | 2015 | 178 | 0.110 |
Why?
| Colorado | 4 | 2024 | 4445 | 0.100 |
Why?
| Exfoliation Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
| Nerve Degeneration | 1 | 2012 | 46 | 0.100 |
Why?
| Mutation, Missense | 2 | 2015 | 319 | 0.090 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2011 | 55 | 0.090 |
Why?
| Male | 14 | 2024 | 63248 | 0.090 |
Why?
| Managed Care Programs | 2 | 2022 | 135 | 0.090 |
Why?
| DNA | 2 | 2015 | 1407 | 0.090 |
Why?
| PC12 Cells | 1 | 2010 | 41 | 0.090 |
Why?
| Databases, Genetic | 1 | 2011 | 226 | 0.080 |
Why?
| Nerve Growth Factors | 1 | 2010 | 74 | 0.080 |
Why?
| Female | 13 | 2024 | 68274 | 0.080 |
Why?
| Transforming Growth Factor beta | 1 | 2012 | 460 | 0.080 |
Why?
| Nuclear Matrix-Associated Proteins | 1 | 2009 | 5 | 0.080 |
Why?
| Gene Frequency | 2 | 2025 | 503 | 0.080 |
Why?
| Distal Myopathies | 1 | 2009 | 9 | 0.080 |
Why?
| Aged | 6 | 2024 | 22068 | 0.080 |
Why?
| Nucleus Accumbens | 1 | 2010 | 128 | 0.080 |
Why?
| Informed Consent | 2 | 2020 | 180 | 0.070 |
Why?
| Middle Aged | 7 | 2024 | 31024 | 0.070 |
Why?
| Emergency Service, Hospital | 1 | 2018 | 1978 | 0.070 |
Why?
| Aged, 80 and over | 2 | 2024 | 7063 | 0.070 |
Why?
| RNA-Binding Proteins | 1 | 2009 | 382 | 0.060 |
Why?
| Phosphorylation | 1 | 2010 | 1686 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2010 | 2082 | 0.060 |
Why?
| Nerve Tissue Proteins | 1 | 2008 | 570 | 0.060 |
Why?
| Phenethylamines | 1 | 2024 | 23 | 0.060 |
Why?
| Torsades de Pointes | 1 | 2024 | 22 | 0.060 |
Why?
| Age Factors | 1 | 2011 | 3137 | 0.050 |
Why?
| Genetics, Population | 1 | 2025 | 200 | 0.050 |
Why?
| Rats | 2 | 2010 | 5254 | 0.050 |
Why?
| Biology | 1 | 2024 | 83 | 0.050 |
Why?
| Dentate Gyrus | 1 | 2002 | 29 | 0.050 |
Why?
| Alleles | 2 | 2018 | 847 | 0.050 |
Why?
| Genes, Dominant | 2 | 2015 | 92 | 0.050 |
Why?
| Phenotype | 3 | 2015 | 3062 | 0.050 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 111 | 0.050 |
Why?
| Genome, Viral | 1 | 2022 | 131 | 0.050 |
Why?
| Dendrites | 1 | 2002 | 101 | 0.050 |
Why?
| Syndrome | 2 | 2015 | 343 | 0.050 |
Why?
| Sequence Analysis, DNA | 2 | 2015 | 778 | 0.050 |
Why?
| Heterozygote | 2 | 2014 | 269 | 0.050 |
Why?
| Pedigree | 2 | 2015 | 491 | 0.050 |
Why?
| Case-Control Studies | 2 | 2024 | 3336 | 0.050 |
Why?
| Axons | 1 | 2002 | 184 | 0.050 |
Why?
| Models, Statistical | 1 | 2025 | 627 | 0.040 |
Why?
| Consent Forms | 1 | 2020 | 13 | 0.040 |
Why?
| Sulfonamides | 1 | 2024 | 494 | 0.040 |
Why?
| Vitamin K Epoxide Reductases | 1 | 2020 | 12 | 0.040 |
Why?
| Computer Simulation | 1 | 2025 | 943 | 0.040 |
Why?
| Antidepressive Agents | 1 | 2022 | 226 | 0.040 |
Why?
| Ultrasonography | 1 | 2024 | 727 | 0.040 |
Why?
| Time Factors | 1 | 2010 | 6579 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2024 | 1842 | 0.040 |
Why?
| Genotype | 1 | 2024 | 1835 | 0.040 |
Why?
| Phylogeny | 1 | 2022 | 844 | 0.040 |
Why?
| Amino Acid Substitution | 2 | 2010 | 283 | 0.040 |
Why?
| Prevalence | 1 | 2024 | 2541 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2024 | 952 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 5365 | 0.040 |
Why?
| Workflow | 1 | 2018 | 150 | 0.040 |
Why?
| Electronic Health Records | 1 | 2024 | 971 | 0.030 |
Why?
| Signal Transduction | 1 | 2010 | 4867 | 0.030 |
Why?
| Cell Proliferation | 1 | 2024 | 2344 | 0.030 |
Why?
| Mice | 2 | 2010 | 16583 | 0.030 |
Why?
| Phosphotransferases | 1 | 2015 | 26 | 0.030 |
Why?
| Computational Biology | 1 | 2018 | 588 | 0.030 |
Why?
| Chromosome Mapping | 1 | 2015 | 505 | 0.030 |
Why?
| Neurons | 1 | 2002 | 1437 | 0.030 |
Why?
| Child | 3 | 2020 | 20860 | 0.030 |
Why?
| Codon, Nonsense | 1 | 2014 | 40 | 0.030 |
Why?
| Depression | 1 | 2022 | 1290 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2015 | 356 | 0.030 |
Why?
| Drug Combinations | 1 | 2014 | 327 | 0.030 |
Why?
| Animals | 3 | 2010 | 34708 | 0.030 |
Why?
| Child, Preschool | 2 | 2018 | 10462 | 0.020 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2012 | 39 | 0.020 |
Why?
| Optic Nerve | 1 | 2012 | 65 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2024 | 2016 | 0.020 |
Why?
| Hippocampus | 2 | 2008 | 791 | 0.020 |
Why?
| RNA, Untranslated | 1 | 2012 | 114 | 0.020 |
Why?
| Risk Factors | 1 | 2024 | 9804 | 0.020 |
Why?
| RNA, Long Noncoding | 1 | 2012 | 176 | 0.020 |
Why?
| Bulgaria | 1 | 2009 | 1 | 0.020 |
Why?
| Nuclear Matrix | 1 | 2009 | 6 | 0.020 |
Why?
| Dysphonia | 1 | 2009 | 12 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 480 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2009 | 370 | 0.020 |
Why?
| Blotting, Northern | 1 | 2008 | 202 | 0.020 |
Why?
| Maze Learning | 1 | 2008 | 93 | 0.020 |
Why?
| Electroshock | 1 | 2008 | 143 | 0.020 |
Why?
| Gene Targeting | 1 | 2008 | 81 | 0.020 |
Why?
| Reflex, Startle | 1 | 2008 | 61 | 0.020 |
Why?
| Adolescent | 2 | 2018 | 20241 | 0.020 |
Why?
| Deglutition Disorders | 1 | 2009 | 129 | 0.020 |
Why?
| Age of Onset | 1 | 2009 | 494 | 0.020 |
Why?
| Food Preferences | 1 | 2008 | 112 | 0.020 |
Why?
| Amygdala | 1 | 2008 | 182 | 0.020 |
Why?
| Memory | 1 | 2008 | 231 | 0.020 |
Why?
| Social Environment | 1 | 2008 | 291 | 0.020 |
Why?
| Cerebellum | 1 | 2008 | 216 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 957 | 0.020 |
Why?
| Fear | 1 | 2008 | 317 | 0.020 |
Why?
| Base Sequence | 1 | 2009 | 2157 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2009 | 2050 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2009 | 2846 | 0.010 |
Why?
| Biolistics | 1 | 2002 | 2 | 0.010 |
Why?
| United States | 1 | 2020 | 13992 | 0.010 |
Why?
| Retrospective Studies | 1 | 2020 | 14562 | 0.010 |
Why?
| Mice, Knockout | 1 | 2008 | 2774 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2002 | 1061 | 0.010 |
Why?
| Treatment Outcome | 1 | 2014 | 10256 | 0.010 |
Why?
| Cell Survival | 1 | 2002 | 1085 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2009 | 1629 | 0.010 |
Why?
| Young Adult | 1 | 2015 | 12310 | 0.010 |
Why?
| Epilepsy | 1 | 2002 | 315 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 1697 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2002 | 2311 | 0.010 |
Why?
| Cells, Cultured | 1 | 2002 | 4063 | 0.010 |
Why?
|
|
Crooks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|